PROVECTUS BIOPHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Diluted Shares Outstanding (Weighted Average) of 420.28 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 420.28M shares, a 0.00% change year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 420.28M shares, a 0.00% change year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 420.28M shares, a 0.00% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 420.28M shares, a 0.09% increase year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 420.28M shares, a 0.11% increase from fiscal 2024.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 419.81M shares, a 0.07% increase from fiscal 2023.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 419.51M shares, a 0.01% increase from fiscal 2022.
- PROVECTUS BIOPHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 419.47M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 420.28M shares 10-Q · filed 2026-08-13 | 420.28M shares 10-Q · filed 2026-08-13 | 420.28M shares derived: average of 3 quarters · filed 2026-08-13 | 420.28M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 420.28M shares 10-Q · filed 2026-05-14 | 420.28M shares derived: average of 2 quarters · filed 2026-05-14 | 420.28M shares derived: average of 3 quarters · filed 2026-05-14 | 420.28M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 420.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 420.28M shares derived: average of 2 quarters · filed 2026-03-26 | 420.28M shares derived: average of 3 quarters · filed 2026-08-13 | 420.28M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 420.28M shares 10-Q · filed 2025-11-13 | 420.28M shares derived: average of 2 quarters · filed 2026-08-13 | 420.28M shares 10-Q · filed 2025-11-13 | 420.28M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 420.28M shares 10-Q · filed 2026-08-13 | 420.28M shares 10-Q · filed 2026-08-13 | 420.28M shares derived: average of 3 quarters · filed 2026-08-13 | 420.19M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 420.28M shares 10-Q · filed 2026-05-14 | 420.28M shares derived: average of 2 quarters · filed 2026-05-14 | 420.16M shares derived: average of 3 quarters · filed 2026-05-14 | 420.00M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 420.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 420.10M shares derived: average of 2 quarters · filed 2026-03-26 | 419.91M shares derived: average of 3 quarters · filed 2026-03-26 | 419.81M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 419.91M shares 10-Q · filed 2025-11-13 | 419.71M shares derived: average of 2 quarters · filed 2025-11-13 | 419.65M shares 10-Q · filed 2025-11-13 | 419.62M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 419.52M shares 10-Q · filed 2025-08-14 | 419.52M shares 10-Q · filed 2025-08-14 | 419.52M shares derived: average of 3 quarters · filed 2025-08-14 | 419.52M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 419.52M shares 10-Q · filed 2025-05-14 | 419.52M shares derived: average of 2 quarters · filed 2025-05-14 | 419.52M shares derived: average of 3 quarters · filed 2025-05-14 | 419.51M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 419.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 419.52M shares derived: average of 2 quarters · filed 2025-03-28 | 419.51M shares derived: average of 3 quarters · filed 2025-03-28 | 419.51M shares 10-K · filed 2025-03-28 |
| 2023-09-30 | 419.52M shares 10-Q · filed 2024-11-12 | 419.51M shares derived: average of 2 quarters · filed 2024-11-12 | 419.50M shares 10-Q · filed 2024-11-12 | 419.50M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 419.50M shares 10-Q · filed 2024-08-13 | 419.50M shares 10-Q · filed 2024-08-13 | 419.50M shares derived: average of 3 quarters · filed 2024-08-13 | 419.50M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 419.50M shares 10-Q · filed 2024-05-14 | 419.50M shares derived: average of 2 quarters · filed 2024-05-14 | 419.49M shares derived: average of 3 quarters · filed 2024-05-14 | 419.48M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 419.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 419.49M shares derived: average of 2 quarters · filed 2024-03-28 | 419.48M shares derived: average of 3 quarters · filed 2024-03-28 | 419.47M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 419.49M shares 10-Q · filed 2023-11-14 | 419.47M shares derived: average of 2 quarters · filed 2023-11-14 | 419.46M shares 10-Q · filed 2023-11-14 | |
| 2022-06-30 | 419.45M shares 10-Q · filed 2023-08-14 | 419.45M shares 10-Q · filed 2023-08-14 |